Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/2012
11/08/2012US20120282219 Peptidomimetic protease inhibitors
11/08/2012US20120282196 Smoothened polypeptides and methods of use
11/08/2012CA2832464A1 Novel agonists and antagonists of the urotensinergic system
11/07/2012EP2520308A1 Composition for improving brain function and method for improving brain function
11/07/2012EP2519538A1 Cyclosporine analogues
11/07/2012CN102770766A Amyloid beta aggregates in cerebro spinal fluid as biomarkers for alzheimer's disease
11/07/2012CN102770446A Oligopeptide improving differentiation of osteoblasts
11/07/2012CN102770442A Cyclic peptides for the regulation of vectorial ion channels
11/07/2012CN102770441A TMEM22 peptides and vaccines including the same
11/07/2012CN102766197A Novel HRP5 analogues and its preparation method
11/07/2012CN102766196A Cation antibacterial peptides, their preparation method and application
11/07/2012CN102766195A Monoclonal antibody recongnizing epitope for HCV (hepatitis C virus) NS3 helicase ATP (adenosine triphosphate) binding site
11/07/2012CN102766194A Oligopeptide compound with HIV-1 protease inhibitory activity, and preparation method and application thereof
11/07/2012CN102250213B Matrix metalloproteinase-9 polypeptide inhibitor 3 and application thereof
11/07/2012CN101787071B Purification method of vapreotide
11/07/2012CN101687910B Mammalian expression vector with a highly efficient secretory signal sequence
11/07/2012CN101654474B Crohn's disease antibody epitope peptide and reagent for testing crohn's disease
11/07/2012CN101357937B Method for synthesizing atosiban acetate from solid phase polypeptide
11/06/2012US8304519 Compositions and methods for modulating dopamine neurotransmission
11/06/2012US8304393 Epithelial cell growth promoter
11/06/2012US8304392 Pharmaceutical and/or cosmetic composition containing an active principle activator of cytochrome C
11/06/2012US8304382 Anti-inflammatory and anti-allergic cyclic peptides
11/06/2012US8304211 Methods of screening molecular libraries and active molecules identified thereby
11/06/2012US8303962 Antibacterial and antifungal peptides
11/01/2012WO2012149242A1 Aptamer -modified polymeric materials for the binding of therapeutic factors in a wound environment
11/01/2012WO2012148720A2 Anti-microbial peptides and methods of use thereof
11/01/2012WO2012147497A1 Synthetic vitreous material
11/01/2012WO2012146901A1 Novel polypeptides and use thereof
11/01/2012WO2012146099A1 Intermediate for synthesizing caspofungin and preparation method therefor
11/01/2012WO2012118972A8 Process of preparing guanylate cyclase c agonists
11/01/2012WO2012080929A3 Use of ide as a biomarker for a scalp condition
11/01/2012US20120277166 Conotoxin peptides useful as inhibitors of neuronal amine transporters
11/01/2012US20120277160 Composition for improving brain function and method for improving brain function
11/01/2012US20120277158 Compositions and methods for the transport of therapeutic agents
11/01/2012US20120276107 Methods and Compositions for Mycoplasma Pneumoniae Exotoxins
11/01/2012US20120276082 Treatment of cancer
11/01/2012US20120276039 Aptamer-modified polymeric materials for the binding of factors in a wound environment
11/01/2012CA2833206A1 Intermediate for synthesizing caspofungin and preparation method therefor
11/01/2012CA2828634A1 Aptamer -modified polymeric materials for the binding of therapeutic factors in a wound environment
10/2012
10/31/2012EP2518149A1 HLA-A*3303-restricted WT1 peptide and pharmaceutical composition comprising the same
10/31/2012EP2518142A1 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
10/31/2012EP2518082A2 Means for the inhibition of anti-beta1-adrenergic receptor antibodies
10/31/2012EP2518080A2 Antibiotic peptides
10/31/2012EP2517720A1 Stabilized therapeutic small helical antiviral peptides
10/31/2012EP2516470A1 Antibodies to non-functional oligomeric p2x7 receptors
10/31/2012CN102762595A Antibodies to non-functional oligomeric p2x7 receptors
10/31/2012CN102762587A Novel anti-ageing peptides modulating survivin and compositions including same
10/31/2012CN102762586A Therapeutic peptides
10/31/2012CN102757482A Polypeptide and application thereof
10/31/2012CN102757481A Function epitopes of staphylococcal enterotoxin B (SEB), monoclonal antibodies specifically bound with function epitopes and application of monoclonal antibodies
10/31/2012CN101921315B Artificially synthesized signal peptide and application thereof
10/30/2012US8299214 Influenza infection-inhibiting peptide, influenza virus infection inhibitor, liposome, and influenza preventive/therapeutic agent
10/30/2012US8299213 Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses
10/30/2012US8299209 Pharmaceutical composition comprising cyclic somatostatin analogues
10/30/2012US8299129 Peptide lipid-containing carrier and method for introducing compound into cells using same
10/30/2012US8299032 Self-assembling peptide and gel produced from the same
10/30/2012US8299030 Peptide-based compounds
10/30/2012US8299020 Antimicrobial peptides and methods of their use
10/30/2012US8298835 Proteolytic markers as diagnostic biomarkers for cancer, organ injury and muscle rehabilitation/exercise overtraining
10/30/2012US8298782 Reversible MHC multimer staining for functional purification of antigen-specific T cells
10/30/2012CA2549185C Peptide inhibiting angiotensin converting enzyme
10/30/2012CA2360106C Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies
10/30/2012CA2230111C Antisecretory factor peptides regulating pathological permeability changes
10/26/2012WO2012145680A2 Anti-microbial peptides and uses therefore
10/26/2012WO2012144790A1 Cyclic peptide from nonomuraea sp., process for the production thereof, and pharmaceutical composition for the prevention or treatment of mycobacteria related disease comprising the same
10/26/2012WO2012144546A1 Novel peptide
10/26/2012WO2012143293A1 Method for purification of micafungin
10/26/2012WO2012142959A1 High purity of caspofungin or salts thereof, and preparation method therefor, and use thereof
10/26/2012WO2012142930A1 Anti-fatty acid synthase polypeptide and use thereof
10/26/2012WO2012142855A1 Antibiotic peptide and preparation method therefor and application thereof
10/26/2012WO2012142659A1 Site-selective modification of proteins
10/26/2012WO2012112767A3 Collagen-targeted nanoparticles
10/26/2012WO2012110636A3 Carrier peptides for cell delivery
10/26/2012WO2012031250A8 Compositions for labeling nerves and methods of use
10/26/2012CA2832145A1 Method for purification of micafungin
10/25/2012US20120271034 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof
10/25/2012US20120270811 Conformations of divergent peptides with mineral binding affinity
10/25/2012US20120270808 Compositions and methods related to synchronous selection of homing peptides for multiple tissues by in vivo phage display
10/25/2012US20120270806 Designer Cyclic Peptides - HIV gp120 Antagonists and their Applications
10/25/2012US20120270798 Compositions and Methods for Preventing or Treating Cancer
10/25/2012US20120270795 Compounds for the treatment of diseases related to protein misfolding
10/25/2012US20120270791 Methods and Compositions for Treating and Diagnosing Kidney Disease
10/25/2012US20120270785 Therapy and Prevention of Problem Drinking
10/25/2012US20120270770 Anti-angiogenic peptides and their uses
10/25/2012US20120270768 Tumor Activated Prodrugs
10/25/2012US20120270767 Tumor Activated Prodrugs
10/25/2012US20120270741 Biomarker discovery in complex biological fluid using bead or particle based libraries and diagnostic kits and therapeutics
10/25/2012US20120270238 Peptides That Bind the Alpha-Fetoprotein (AFP) Receptor and Uses Thereof
10/25/2012US20120270208 Synthetic antigens for the detection of antibodies to hepatitis c virus
10/25/2012US20120269885 Vaccine for Modulating Between T1 and T2 Immune Responses
10/25/2012US20120269884 Vaccine for Modulating Between T1 and T2 Immune Responses
10/25/2012US20120269843 S. epidermidis antigens
10/25/2012US20120269838 Carrier conjugates of il-23-peptides and their induced antibodies
10/25/2012US20120269837 SUBSTANCE BINDING HUMAN IgG Fc RECEPTOR IIb (FcgammaRIIb)
10/25/2012US20120269829 Inhibitors of Phosphatase and Tensin Homolog (PTEN) Compositions, Uses and Methods
10/25/2012US20120269815 Neurotrophins and uses thereof
10/25/2012US20120269764 RBM3 as a Marker for Malignant Melanoma Prognosis
10/24/2012EP2514761A1 Crystal of recombinant interferon with altered spatial configuration, three-dimensional structure and uses thereof
10/24/2012EP2513137A2 Saposin-a derived peptides and uses thereof
10/24/2012EP2513136A1 Tmem22 peptides and vaccines including the same
1 ... 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 ... 423